Daiwa Securities Group’s Harmony Biosciences HRMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $6K | Hold |
189
| – | – | ﹤0.01% | 1147 |
|
|
2025
Q1 | $6K | Hold |
189
| – | – | ﹤0.01% | 1122 |
|
|
2024
Q4 | $7K | Hold |
189
| – | – | ﹤0.01% | 1145 |
|
|
2024
Q3 | $8K | Hold |
189
| – | – | ﹤0.01% | 1142 |
|
|
2024
Q2 | $6K | Sell |
189
-50
| -21% | -$1.59K | ﹤0.01% | 1181 |
|
|
2024
Q1 | $8K | Hold |
239
| – | – | ﹤0.01% | 1170 |
|
|
2023
Q4 | $8K | Hold |
239
| – | – | ﹤0.01% | 1172 |
|
|
2023
Q3 | $8K | Hold |
239
| – | – | ﹤0.01% | 1130 |
|
|
2023
Q2 | $8K | Hold |
239
| – | – | ﹤0.01% | 1140 |
|
|
2023
Q1 | $8K | Hold |
239
| – | – | ﹤0.01% | 1112 |
|
|
2022
Q4 | $13K | Buy |
239
+19
| +9% | +$1.03K | ﹤0.01% | 1095 |
|
|
2022
Q3 | $10K | Hold |
220
| – | – | ﹤0.01% | 1118 |
|
|
2022
Q2 | $11K | Buy |
220
+49
| +29% | +$2.45K | ﹤0.01% | 1129 |
|
|
2022
Q1 | $8K | Hold |
171
| – | – | ﹤0.01% | 1142 |
|
|
2021
Q4 | $7K | Buy |
+171
| New | +$7K | ﹤0.01% | 1161 |
|